Cycle 30 Organism 6
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Produktkatalog 2015/2016
Produktkatalog 2015/2016 BD Life Sciences Diagnostic Systems Deutschland . Österreich . Schweiz BD stellt sich vor BD Lifeweltweit Sciences – BD – LifeBD MedicalSciences – BD Medical BD – weltweit BD Life Sciences – Biosciences BD Life Sciences – Diagnostic Systems BD, eines der führenden Medizintech- Biosciences bedient den gesamten Diagnostic Systems ist Ihr Experte und nologie-Unternehmen, hat es sich zur Bereich der biologischen und medizi- erfahrener Partner für die klinische Aufgabe gemacht, in Zusammenar- nischen Forschung und bietet die und industrielle mikrobiologische Diag- beit mit seinen Kunden und Partnern größte Auswahl an innovativen Gerä- nostik. den gegenwärtigen und zukünftigen ten und Reagenzien für die zelluläre Umfassende Konzepte und daran ge- Herausforderungen bei der Gesund- Analyse an. knüpfte Diagnostika, Softwarelösun- heitsversorgung von Menschen auf Ein breites Spektrum an Analyzern gen und Dienstleistungen führen zu der ganzen Welt zu begegnen. und Sortern für die Durchflusszyto- gesteigerter Effizienz im Labor und Mit innovativen Lösungen optimiert metrie, verbunden mit kompetenter zu schnelleren verwertbaren Ergeb- BD die Arzneimittelverabreichung, Beratung und Service, ermöglichen nissen. verbessert die Diagnose von Infek- die passgenaue Lösung für Ihr Labor. Unser klinischer Fokus liegt in der Prä- tionskrankheiten und Krebs, unter- Unser Produktangebot und unsere vention und Diagnose von Infektions- stützt die Behandlung von Diabetes Kompetenz machen uns zum interes- krankheiten sowie des Zervixkarzinoms. und bringt die Zellforschung voran. santen Partner für Forschungs- und Für den klinischen Bereich bietet Diag- Rund 30.000 BD-Mitarbeiterinnen Routinelabors, für die Industrie sowie nostic Sytems integrierte Lösungen und Mitarbeiter in 50 Ländern setzen für die wachsende Zahl von bio- und auf den Gebieten Tuberkulose, Sep- sich dafür ein, unser Unternehmens- gentechnologischen Einrichtungen. -
The Gut Microbiota of the Egyptian Mongoose As an Early Warning Indicator of Ecosystem Health in Portugal
International Journal of Environmental Research and Public Health Article The Gut Microbiota of the Egyptian Mongoose as an Early Warning Indicator of Ecosystem Health in Portugal Mónica V. Cunha 1,2,3,* , Teresa Albuquerque 1, Patrícia Themudo 1, Carlos Fonseca 4, Victor Bandeira 4 and Luís M. Rosalino 2,4 1 National Institute for Agrarian and Veterinary Research (INIAV, IP), Wildlife, Hunting and Biodiversity R&D Unit, 2780-157 Oeiras, Portugal; [email protected] (T.A.); [email protected] (P.T.) 2 Centre for Ecology, Evolution and Environmental Changes (cE3c), Faculdade de Ciências da Universidade de Lisboa, 1749-016 Lisboa, Portugal; [email protected] 3 Biosystems & Integrative Sciences Institute (BioISI), Faculdade de Ciências da Universidade de Lisboa, 1749-016 Lisboa, Portugal 4 Departamento de Biologia & CESAM, Universidade de Aveiro, 3810-193 Aveiro, Portugal; [email protected] (C.F.); [email protected] (V.B.) * Correspondence: [email protected]; Tel.: +351-214-403-500 Received: 1 April 2020; Accepted: 27 April 2020; Published: 29 April 2020 Abstract: The Egyptian mongoose is a carnivore mammal species that in the last decades experienced a tremendous expansion in Iberia, particularly in Portugal, mainly due to its remarkable ecological plasticity in response to land-use changes. However, this species may have a disruptive role on native communities in areas where it has recently arrived due to predation and the potential introduction of novel pathogens. We report reference information on the cultivable gut microbial landscape of widely distributed Egyptian mongoose populations (Herpestes ichneumon, n = 53) and related antimicrobial tolerance across environmental gradients. -
United States Patent (19) 11 Patent Number: 6,039,992 Compadre Et Al
USOO6039992A United States Patent (19) 11 Patent Number: 6,039,992 Compadre et al. (45) Date of Patent: *Mar. 21, 2000 54 METHOD FOR THE BROAD SPECTRUM Dorsa, W.; "New and Established Carcass Decontamination PREVENTION AND REMOVAL OF Procedures Commonly Used in the Beef-Processing Indus MICROBAL CONTAMINATION OF FOOD try"; Journal of Food Protection, vol. 60, No. 9, 1997, pp. PRODUCTS BY QUATERNARY AMMONIUM 1146-1151. COMPOUNDS Kotula, K. et al., “Reduction of Aqueous Chlorine by Organic Material'; Journal of Food Protection, vol. 60, No. 75 Inventors: Cesar Compadre; Philip Breen; 3, 1997, pp. 276-282. Hamid Salari; E. Kim Fifer, all of Little Rock, Ark., Danny L. Lattin, Delazari, I. et al., “Decontaminating Beef for Escherichia Brookings, S. Dak.; Michael Slavik, coli O157:H7'; Journal of Food Protection, vol. 61, No. 5, Springdale, Ark., Yanbin Li, Fatettville, 1998, pp. 547-550. Ark.; Timothy O'Brien, Little Rock, Dalgaard, P. et al., “Specific Inhibition of Photobacterium Ark. phosphoreum Extends the Shelf Lift of Modified-Atmo sphere-Packed Cod Fillets”; Journal of Food Protection, 73 Assignee: University of Arkansas, Little Rock, vol. 61, No. 9, 1998, pp. 1191–1194. Ark. Fisher, T. et al., “Fate of Escherichia coli O157:H7 in Ground Apples Used in Cider Production; Journal of Food Protec * Notice: This patent is Subject to a terminal dis tion, vol. 61, No. 10, 1998, pp. 1372–1374. claimer. Wang, W. et al., “Trisodium Phosphate and Cetylpyridinum Chloride Spraying on Chichen Skin to Reduce Attached 21 Appl. No.: 08/840,288 Salmonella typhimurium”: Journal of Food Protection, vol. 22 Filed: Apr. -
Uscepti- Bility Testing of Anaerobic Bacteria
XL Agar Base References Availability 1. Wilkins and Chalgren. 1976. Antimicrob. Agents Chemother. 10:926. Difco™ Wilkins-Chalgren Agar 2. National Committee for Clinical Laboratory Standards. 1993. Methods for antimicrobial suscepti- bility testing of anaerobic bacteria. Approved standard M11-A3. NCCLS, Villanova, Pa. NCCLS 3. Wexler and Doern. 1995. In Murray, Baron, Pfaller, Tenover and Yolken (ed.). Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C. Cat. No. 218051 Dehydrated – 500 g 4. Isenberg (ed.). 1995. Clinical microbiology procedures handbook, vol 1. American Society for ™ Microbiology, Washington, D.C. Difco Anaerobe Broth MIC NCCLS Cat. No. 218151 Dehydrated – 500 g XL Agar Base • XLD Agar Intended Use It is particularly recommended for obtaining counts of enteric XLD Agar conforms with specifications of The United States organisms. This medium can be rendered moderately selective Pharmacopeia (USP). for enteric pathogens, particularly Shigella, by the addition of sodium desoxycholate (2.5 g/L) to make XLD Agar.1 XL (Xylose Lysine) Agar Base is used for the isolation and differ- entiation of enteric pathogens and, when supplemented with XL Agar Base can be made selective for Salmonella by adding appropriate additives, as a base for selective enteric media. 1.25 mL/L of 1% aqueous brilliant green to the base prior to autoclaving. Its use is recommended for Salmonella isolation XLD Agar is the complete Xylose Lysine Desoxycholate Agar, after selenite or tetrathionate enrichment in food analysis; both a moderately selective medium recommended for isolation and coliforms and Shigella are inhibited.1 differentiation of enteric pathogens, especially Shigella species. -
Microbiology (Cbcs Structure)
B.Sc. (HONOURS) MICROBIOLOGY (CBCS STRUCTURE) Proposed Scheme for Choice Based Credit System in B.Sc. Honours in Microbiology Year Semester Core Course Ability Skill enhancement Discipline Specific Generic (14 Papers) enhancement course (SEC)(any 2 Elective Course Elective Course 6 credits compulsory papers) (2 Credits (any 4 papers)(6 (any 4 papers) each course each) credits each (6 credits each) (AECC)(2 papers) (2 credits each) I Paper 1 AECC-1 GE-1/2 Paper 2 Paper 1/2 1 (Any one) II Paper 3 AECC-2 GE-1/2 Paper 3/4 Paper 4 (Any one) III Paper 5 SEC-Paper 1/2 GE-1/2 Paper 6 (Any one) Paper 1/2 2 Paper 7 (Any one) IV Paper 8 SEC-Paper 3/4 GE-1/2 Paper 9 (Any one) Paper 3/4 Paper 10 (Any one) V Paper 11 DSE- Paper 1/2(Any one) Paper 12 DSE- Paper 3/4 (Any one) 3 VI Paper 13 DSE- Paper 5/6 Paper 14 (Any one) DSE- Paper 7/8 (Any one) UNIVERSITY OF NORTH BENGAL Page 1 B.Sc. (HONOURS) MICROBIOLOGY (CBCS STRUCTURE) Overall distribution of credits and marks in B.Sc.(Hons.) In Microbiology Course Total Credits /per Total papers Theory Practical Credits I.Core 14 4 2 14X6=84 Courses II.DSE 4 4 2 4X6=24 III.GE 4 4 2 4X6=24 IV.AECC 2 2 - 2x2=4 V.SEC 2 2 - 2x2=4 Grand 140 total UNIVERSITY OF NORTH BENGAL Page 2 B.Sc. (HONOURS) MICROBIOLOGY (CBCS STRUCTURE) Structure of B. -
Utilization of Synbiotics, Acidifiers, and a Polyanhydride Nanoparticle
Utilization of Synbiotics, Acidifiers, and a Polyanhydride Nanoparticle Vaccine in Enhancing the Anti-Salmonella Immune Response in Laying Hens Post-Salmonella Challenge Dissertation Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Ashley D. Markazi, M.S. Graduate Program in Animal Sciences The Ohio State University 2018 Dissertation Committee: Ramesh K. Selvaraj, Advisor Michael S. Lilburn, Co-Advisor Renukaradhya Gourapura Lisa Bielke Copyright by Ashley D. Markazi 2018 ABSTRACT Salmonellosis, a zoonotic disease caused by the bacterium Salmonella, is most commonly attributed to the consumption of poultry eggs and meat. The current project examined the effects of drinking water synbiotics, in-feed acidifiers, and a polyanhydride nanoparticle Salmonella vaccine in enhancing the anti-Salmonella immune response and decreasing Salmonella infection in laying hens. The synbiotic experiment was conducted to study the effects of drinking water supplementation of synbiotic product in laying hens with and without a Salmonella challenge. A total of 384 one-day-old layer chicks were randomly distributed to the drinking water synbiotic supplementation or control groups. At 14 wk of age, the birds were vaccinated with a Salmonella vaccine, resulting in a 2 (control and synbiotic) X 2 (non-vaccinated and vaccinated) factorial arrangement of treatments. At 24 wk of age, half of the birds in the vaccinated groups and all the birds that were not vaccinated were challenged with Salmonella Enterica serotype Enteritidis, resulting in a 3 (vaccinated, challenged, vaccinated+challenged) X 2 (control and synbiotic) factorial arrangement. At 8 d post-Salmonella challenge, synbiotic supplementation decreased (P = 0.04) cecal S. -
XL Agar Base • XLD Agar
XL Agar Base • XLD Agar clinical evaluations have supported the claim for the relatively Intended Use high efficiency of XLD Agar in the primary isolation ofShigella XL (Xylose Lysine) Agar Base is used for the isolation and and Salmonella.5-9 differentiation of enteric pathogens and, when supplemented with appropriate additives, as a base for selective enteric media. XLD Agar is a selective and differential medium used for the isolation and differentiation of enteric pathogens from clinical XLD Agar is the complete Xylose Lysine Desoxycholate Agar, specimens.10-12 The value of XLD Agar in the clinical laboratory a moderately selective medium recommended for isolation and is that the medium is more supportive of fastidious enteric organ- differentiation of enteric pathogens, especially Shigella species. isms such as Shigella.12 XLD Agar is also recommended for the XLD Agar meets United States Pharmacopeia (USP), European testing of food, dairy products and water in various industrial Pharmacopoeia (EP) and Japanese Pharmacopoeia (JP)1-3 standard test methods.13-17 General Chapter <62> of the USP performance specifications, where applicable. describes the test method for the isolation of Salmonella from nonsterile pharmaceutical products using XLD Agar as the solid Summary and Explanation culture medium.1 A wide variety of media have been developed to aid in the selective isolation and differentiation of enteric pathogens. Due Principles of the Procedure to the large numbers of different microbial species and strains Xylose is incorporated into the medium because it is fermented with varying nutritional requirements and chemical resistance by practically all enterics except for the shigellae. -
The Safety of Ready-To-Eat Meals Under Different Consumer Handling Conditions
Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere without the permission of the Author. The Safety of Ready-to-Eat Meals Under Different Consumer Handling Conditions A thesis presented in partial fulfilment of the requirements for the degree of Master in Food Technology at Massey University, 0DQDZDWnj, New Zealand Fan Jiang 2016 i Abstract Microbial count is an important index to measure the safety status of a food. This trial aimed to determine the safety of eight meals (four meats and four vegetarians) by using the agar plate counting method to measure the populations of total bacteria and specific pathogenic microorganisms during four day’ abusing. The results showed that chicken & lemon sauce, pork & cranberry loaf and lasagne veg can be considered as acceptable after a series of handling steps including heating and holding in different environments. BBQ beef, quiche golden and pie rice & vegetable were all marginal for the microbial load before heating, but afterwards all of them were acceptable. Casserole chickpea and hot pot sausage were in marginal for the microbial load by the end of trial. Keywords: microbial count; eight meals; pathogenic microorganisms ii Acknowledgements I am like to acknowledge my chief supervisor Prof. Steve Flint for his consistent support and guidance. Without his insightful advice, this project would not go smoothly. I learnt a lot from him how to deal with the challenges faced in the research. I am also grateful to Mrs Julia Good at the Microbiology Laboratory for providing me with her expert guidance on the experimental operation. -
Salmonella Typhimurium Infection Disrupts but Continuous Feeding of Bacillus Based Probiotic Restores Gut Microbiota in Infected Hens Samiullah Khan and Kapil K
Khan and Chousalkar Journal of Animal Science and Biotechnology (2020) 11:29 https://doi.org/10.1186/s40104-020-0433-7 RESEARCH Open Access Salmonella Typhimurium infection disrupts but continuous feeding of Bacillus based probiotic restores gut microbiota in infected hens Samiullah Khan and Kapil K. Chousalkar* Abstract Background: The gut microbiota plays an important role in the colonisation resistance and invasion of pathogens. Salmonella Typhimurium has the potential to establish a niche by displacing the microbiota in the chicken gut causing continuous faecal shedding that can result in contaminated eggs or egg products. In the current study, we investigated the dynamics of gut microbiota in laying chickens during Salmonella Typhimurium infection. The optimisation of the use of an infeed probiotic supplement for restoration of gut microbial balance and reduction of Salmonella Typhimurium load was also investigated. Results: Salmonella infection caused dysbiosis by decreasing (FDR < 0.05) the abundance of microbial genera, such as Blautia, Enorma, Faecalibacterium, Shuttleworthia, Sellimonas, Intestinimonas and Subdoligranulum and increasing the abundance of genera such as Butyricicoccus, Erysipelatoclostridium, Oscillibacter and Flavonifractor. The higher Salmonella Typhimurium load resulted in lower (P < 0.05) abundance of genera such as Lactobacillus, Alistipes, Bifidobacterium, Butyricimonas, Faecalibacterium and Romboutsia suggesting Salmonella driven gut microbiota dysbiosis. Higher Salmonella load led to increased abundance of genera such as Caproiciproducens, Acetanaerobacterium, Akkermansia, Erysipelatoclostridium, Eisenbergiella, EscherichiaShigella and Flavonifractor suggesting a positive interaction of these genera with Salmonella in the displaced gut microbiota. Probiotic supplementation improved the gut microbiota by balancing the abundance of most of the genera displaced by the Salmonella challenge with clearer effects observed with continuous supplementation of the probiotic. -
Enhanced Salmonella Virulence Instigated by Bactivorous Protozoa
Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2014 Enhanced Salmonella virulence instigated by bactivorous protozoa and investigation of putative protozoan G protein-coupled receptors associated with bacterial engulfment Matt .T Brewer Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Pharmacology Commons Recommended Citation Brewer, Matt .,T "Enhanced Salmonella virulence instigated by bactivorous protozoa and investigation of putative protozoan G protein-coupled receptors associated with bacterial engulfment" (2014). Graduate Theses and Dissertations. 13718. https://lib.dr.iastate.edu/etd/13718 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Enhanced Salmonella virulence instigated by bactivorous protozoa and investigation of putative protozoan G protein-coupled receptors associated with bacterial engulfment By Matt Brewer A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Biomedical Sciences (Pharmacology) Program of Study Committee: Steve A. Carlson, Major Professor Tim A. Day Michael Kimber Heather Greenlee Doug Jones Iowa State University Ames, Iowa 2014 Copyright © Matt Brewer, 2014. All rights reserved ii DEDICATION This work is dedicated to my family. To my Mom, who taught me the value of education. To my Dad, who instilled in me a deep appreciation for the diversity of life and the scientific process used to investigate it. -
OXOID MANUAL PRELIMS 16/6/06 12:18 Pm Page 1
OXOID MANUAL PRELIMS 16/6/06 12:18 pm Page 1 The OXOID MANUAL 9th Edition 2006 Compiled by E. Y. Bridson (substantially revised) (former Technical Director of Oxoid) Price: £50 OXOID MANUAL PRELIMS 16/6/06 12:18 pm Page 2 The OXOID MANUAL 9th Edition 2006 Compiled by E. Y. Bridson (substantially revised) (former Technical Director of Oxoid) 9th Edition 2006 Published by OXOID Limited, Wade Road, Basingstoke, Hampshire RG24 8PW, England Telephone National: 01256 841144 International: +44 1256 841144 Email: [email protected] Facsimile National: 01256 463388 International: +44 1256 463388 Website http://www.oxoid.com OXOID SUBSIDIARIES AROUND THE WORLD AUSTRALIA DENMARK NEW ZEALAND Oxoid Australia Pty Ltd Oxoid A/S Oxoid NZ Ltd 20 Dalgleish Street Lunikvej 28 3 Atlas Place Thebarton, Adelaide DK-2670 Greve, Denmark Mairangi Bay South Australia 5031, Australia Tel: 45 44 97 97 35 Auckland 1333, New Zealand Tel: 618 8238 9000 or Fax: 45 44 97 97 45 Tel: 00 64 9 478 0522 Tel: 1 800 331163 Toll Free Email: [email protected] NORWAY Fax: 618 8238 9060 or FRANCE Oxoid AS Fax: 1 800 007054 Toll Free Oxoid s.a. Nils Hansen vei 2, 3 etg Email: [email protected] 6 Route de Paisy BP13 0667 Oslo BELGIUM 69571 Dardilly Cedex, France PB 6490 Etterstad, 0606 Oxoid N.V./S.A. Tel: 33 4 72 52 33 70 Oslo, Norway Industriepark, 4E Fax: 33 4 78 66 03 76 Tel: 47 23 03 9690 B-9031 Drongen, Belgium Email: [email protected] Fax: 47 23 09 96 99 Tel: 32 9 2811220 Email: [email protected] GERMANY Fax: 32 9 2811223 Oxoid GmbH SPAIN Email: [email protected] Postfach 10 07 53 Oxoid S.A. -
Laboratory Diagnosis of Shigella and Salmonella Infections *
Bull. Org. mond. Sante) 1959, 21, Bull. Wid Hlth Org. 247-277 Laboratory Diagnosis of Shigella and Salmonella Infections * E. HORMAECHE, M.D.' & C. A. PELUFFO, M.D.2 In recent years a great deal of work has been We are aware that experienced bacteriologists devoted to the study of enteric diseases and, in will prefer some of the methods they are using to consequence, many methods have been developed the ones we recommend. This study is not in- for the isolation of their most common agents, tended for them, however, but rather as a guide to Shigella, Salmonella and some pathogenic Esche- people who are just starting work on enteric diseases richia, while at the same time new tests have been diagnosis. For more detailed information, we devised to differentiate the " groups " of the Entero- recommend the books of Kauffmann (1954) and bacteriaceae family, so that the beginner, especially, Edwards & Ewing (1955), of which we have made will be faced with the difficulty of selecting from ample use. among them those to be used. Investigation of enteric pathogens will sometimes Each author has his preferences according to his be the ultimate purpose, as for the public health own experience, and it is regrettable that up to now officer, who is primarily interested in finding them no serious effort has been made to standardize for the potential danger they represent to the com- techniques, which would save a lot of time and dis- munity. In clinical medicine, however, the role couraging failures for the bacteriologist unex- played by the bacteriologist does not end there.